
May 1 (Reuters) - Amgen Inc AMGN.O:
AMGEN Q1 ADJUSTED EPS $4.90 VERSUS IBES ESTIMATE $4.30
AMGEN Q1 TOTAL REVENUE $8.15 BILLION VERSUS IBES ESTIMATE $8.06 BILLION
AMGEN OUTLOOK FY TOTAL REVENUE $34.3 BILLION TO $35.7 BILLION VERSUS IBES ESTIMATE $35.09 BILLION
AMGEN: 2025 SHARE REPURCHASES NOT TO EXCEED $500 MILLION
AMGEN: 2025 OUTLOOK INCLUDES ESTIMATED IMPACT OF IMPLEMENTED TARIFFS, BUT DOES NOT ACCOUNT FOR ANY FUTURE LEVIES
AMGEN OUTLOOK FY ADJUSTED EPS $20.00 TO $21.20 VERSUS IBES ESTIMATE $20.64
AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING PEOPLE LIVING WITH OBESITY AFTER REMOVAL OF CLINICAL HOLD BY U.S. FDA